The portfolio will be transferred to Lupin on Dec. 31, subject to regulatory approvals and certain closing conditions, the companies said
Read More
Verily Life Sciences - known as Google's life sciences unit until last year - and Britain's biggest drugmaker will together contribute 540 million pounds over seven years to Galvani Bioelectronics
Read More
Indoco Remedies on Friday reported a marginal decline in net profit at Rs 19.8 crore for the June quarter against Rs 20.8 crore in the corresponding period last fiscal
Read More
The product is a generic version of Santarus Inc’s Zegerid powder for oral suspension, Ajanta Pharma says
Read More
GlaxoSmithKline Pharmaceuticals on Thursday reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter, on account of increase in expenditure
Read More
Biotechnology major Biocon has posted 17 per cent rise in net profit at Rs 147 crore for the first quarter ended June 30 on the back of robust growth in segments like biologics and branded formulations.
Read More
Hyderabad-based Gland Pharma's founders and US private equity firm KKR, who jointly hold roughly 96 per cent of the drugmaker, will sell almost all of their stake to China's Fosun
Read More
Drug firm Torrent Pharmaceuticals has reported 55 per cent fall in consolidated net profit at Rs 292 crore for the June quarter due to a dip in company’s US business
Read More
In May, Shanghai Fosun had made a non-binding proposal to buy Gland Pharma, which is backed by KKR & Co
Read More
Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, said its quarterly profit slumped 75 per cent, hurt by fierce competition in its largest market, the United States
Read More
